MCL coexpression mm9:267

Phase1 CAGE Peaks

	Short description
Mm9::chr10:18724766..18724782,-	p@chr10:18724766..18724782 -
Mm9::chr10:18735010..18735015,-	p6@Tnfaip3
Mm9::chr10:18735109..18735123,-	p2@Tnfaip3
Mm9::chr10:18735153..18735185,-	p1@Tnfaip3
Mm9::chr10:5958538..5958568,+	p1@Zbtb2
Mm9::chr10:92628684..92628719,-	p@chr10:92628684..92628719 -
Mm9::chr11:120435018..120435029,-	p7@P4hb
Mm9::chr12:114099097..114099178,-	p1@Gpr132
Mm9::chr12:60320433..60320481,-	p1@Fbxo33
Mm9::chr14:32149981..32149992,+	p3@Capn7
Mm9::chr15:101084397..101084429,-	p@chr15:101084397..101084429 -
Mm9::chr16:78576894..78576911,-	p1@D16Ertd472e
Mm9::chr16:78576927..78576941,-	p3@D16Ertd472e
Mm9::chr17:71825231..71825243,-	p@chr17:71825231..71825243 -
Mm9::chr17:71948007..71948018,-	p2@ENSMUST00000137830
Mm9::chr19:30105105..30105124,+	p2@Uhrf2
Mm9::chr19:30105132..30105143,+	p3@Uhrf2
Mm9::chr1:162836606..162836631,+	p2@Rc3h1
Mm9::chr2:126501847..126501876,-	p5@Gabpb1
Mm9::chr3:152059025..152059046,+	p4@Gm8261 p4@Zzz3
Mm9::chr4:102242999..102243006,+	p17@Pde4b
Mm9::chr4:48058102..48058110,+	p5@Nr4a3
Mm9::chr4:8738493..8738504,+	p@chr4:8738493..8738504 +
Mm9::chr4:8738510..8738524,+	p@chr4:8738510..8738524 +
Mm9::chr5:52581099..52581110,+	p@chr5:52581099..52581110 +
Mm9::chr7:148042601..148042621,-	p2@Bet1l
Mm9::chr7:150812280..150812293,+	p@chr7:150812280..150812293 +
Mm9::chr7:51053393..51053466,+	p1@Klk8
Mm9::chr7:71083729..71083742,-	p4@Klf13
Mm9::chr8:87501773..87501787,-	p@chr8:87501773..87501787 -
Mm9::chr9:45983558..45983575,-	p@chr9:45983558..45983575 -

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}